NASS is a charity specialising in patient education and support for ankylosing spondylitis, a form of inflammatory arthritis that is primarily diagnosed in younger people. Pfizer supported the redesign of the charity’s newsletter and contributed towards its production costs.
£7,000
As a guide this amount represents 2.8% of the total income of NASS based on their last declared financial year (July 2006 – June 2007).